| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/02/2005 | US20050119219 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119164 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 06/02/2005 | US20050118715 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/02/2005 | US20050118714 Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues |
| 06/02/2005 | US20050118713 Isolating pluripotent embryonic stem cell from human morula cell masses; cell therapy; regenerative medicine; tissue engineering |
| 06/02/2005 | US20050118712 Amniotic fluid-derived MSCs (AFMSCs) were successfully isolated, cultured, and enriched without interfering with the routine process of fetal karyotyping |
| 06/02/2005 | US20050118701 Large scale methods of producing adenovirus and adenovirus seed stocks |
| 06/02/2005 | US20050118700 Immortalized avian cell lines |
| 06/02/2005 | US20050118699 Packaging complementation cell-line for sv-40 vectors |
| 06/02/2005 | US20050118698 Propagating viral particle in BHK (baby hamster kidney) and MDCK (mandine darby canine kidney) cell lines; for use as bioreactor for producing drugs and/or diagnostic agents |
| 06/02/2005 | US20050118696 Methods and means for modulating PGE synthase activity |
| 06/02/2005 | US20050118684 Recombinant antihemophilic factor for use as tool in treatment hemophilia |
| 06/02/2005 | US20050118682 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 06/02/2005 | US20050118652 Rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
| 06/02/2005 | US20050118649 Monitoring protein translocation into preferential cellular compartment via reporter expression of fluorescent protein fusion |
| 06/02/2005 | US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 06/02/2005 | US20050118626 Novel human collagen proteins and polynucleotides encoding the same |
| 06/02/2005 | US20050118610 Nucleotide sequences coding hydrolase for generating protein hydrolysates useful as flavour improving agents; food processing |
| 06/02/2005 | US20050118592 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders |
| 06/02/2005 | US20050118590 Novel gene cluster of pederin biosynthesis genes |
| 06/02/2005 | US20050118581 Novel brain expressed gene and protein associated with bipolar disorder |
| 06/02/2005 | US20050118575 Immune cell polypeptide for use in diagnosis and treatment of cell proliferative disorders |
| 06/02/2005 | US20050118563 Method for determining embryo quality |
| 06/02/2005 | US20050118561 Compositions and methods for propagation of neural progenitor cells |
| 06/02/2005 | US20050118228 Compositions and methods for augmentation or repair of intervertebral discs |
| 06/02/2005 | US20050118204 Methods for controlling membrane permeability of a membrane permeable substance and screening methods for a membrane permeable substance |
| 06/02/2005 | US20050118195 Virus causing respiratory tract illness in susceptible mammals |
| 06/02/2005 | US20050118192 Viral preparations, vectors, immunogens, and vaccines |
| 06/02/2005 | US20050118191 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 06/02/2005 | US20050118183 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 06/02/2005 | US20050118173 Compositions and methods to accelerate hematologic recovery |
| 06/02/2005 | US20050118170 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway |
| 06/02/2005 | US20050118169 For inflammatory diseases; rheumatoid arthritis; hybridoma cell lines |
| 06/02/2005 | US20050118168 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 06/02/2005 | US20050118165 useful for imaging such tumors; scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors |
| 06/02/2005 | US20050118161 Hevein-binding monoclonal antibodies |
| 06/02/2005 | US20050118160 Inhibits delayed vascular rejection; makes organs less vulnerable to rejection after transplantation |
| 06/02/2005 | US20050118150 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 06/02/2005 | US20050118148 Compositions and methods related to mammalian Maf-A |
| 06/02/2005 | US20050118147 Cotransplanting stem cells from multiple stem cell sources such as bone marrow, peripheral blood, or umbilical cord blood; suppressing graft versus host disease |
| 06/02/2005 | US20050118146 In vitro synthesis of a layered cell sorted tissue |
| 06/02/2005 | US20050118145 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 06/02/2005 | US20050118144 Fibrin-based biomatrix |
| 06/02/2005 | US20050118143 Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells |
| 06/02/2005 | US20050118142 Stem cells are from a syngeneic, allogeneic or xenogeneic donor; the composition of donor CD34+ hematopoietic cells in combination with donor alpha beta TCR+ T-cells reduces the risk of Graft Versus Host Disease by half |
| 06/02/2005 | US20050118141 Transplantable lung carcinoma xenograft useful in experimental models of carcinoma in order to dissect out the molecular basis of the phenotype; the model of carcinoma can be used to identify molecular targets, assess the efficacy of theraputic agents |
| 06/02/2005 | US20050118140 Madin Darby Canine Kidney cells are virally infected and cultured in suspension on an industrial scale to produce the active ingredient, and then mixed with a carrier or dilluent |
| 06/02/2005 | US20050118136 Polyaspartic acid or polyglutamic acid end capped by oligopeptides of various amino acid sequences; improved pharmacokinetics, bioavailability and water solubility of conjugated drugs |
| 06/02/2005 | US20050118117 Methods for identifying risk of melanoma and treatments thereof |
| 06/02/2005 | CA2844236A1 Improved targeted dna insertion in plants |
| 06/02/2005 | CA2546406A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 06/02/2005 | CA2546383A1 Rescue agents for treating botulinum toxin intoxications |
| 06/02/2005 | CA2546355A1 Novel atypical pneumonia-causing virus |
| 06/02/2005 | CA2545198A1 Skeletal muscle-derived cells and methods related thereto |
| 06/02/2005 | CA2545049A1 Method for proliferating cardiomyocytes |
| 06/02/2005 | CA2528549A1 Use of epha4 and modulator of epha4 for diagnosis, treatment and prevention of cancer |
| 06/01/2005 | EP1536234A2 Soluble CTLA4 mutant molecules and uses thereof |
| 06/01/2005 | EP1536020A1 Means and methods for optical determination of cAMP in vitro and in vivo |
| 06/01/2005 | EP1536004A1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody |
| 06/01/2005 | EP1535994A1 Human bone stem cells |
| 06/01/2005 | EP1535929A2 Megakaryocyte stimulating factors |
| 06/01/2005 | EP1535628A2 HBV/HCV virus-like particle |
| 06/01/2005 | EP1535067A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 06/01/2005 | EP1535041A1 A method of characterizing dendritic cells |
| 06/01/2005 | EP1534861A1 Sirna-mediated gene silencing with viral vectors |
| 06/01/2005 | EP1534852A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 06/01/2005 | EP1534849A2 Use of malate dehydrogenase for nadh regeneration |
| 06/01/2005 | EP1534847A1 Retroviral vector and stable packaging cell lines |
| 06/01/2005 | EP1534846A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 06/01/2005 | EP1534837A2 Apicomplexan pathways, inhibitiors, and drug delivery |
| 06/01/2005 | EP1534834A2 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 06/01/2005 | EP1534822A1 Immunotherapy using modulators of notch signalling |
| 06/01/2005 | EP1534821A2 Methods for perfusion and plating of primary hepatocytes and a medium therefore |
| 06/01/2005 | EP1534820A2 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 06/01/2005 | EP1534819A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 06/01/2005 | EP1534818A1 Method of immobilization of clusters of ligands on polymer surface and use n cell engineering |
| 06/01/2005 | EP1534754A2 Bi-specific antigen-binding compositions and related methods |
| 06/01/2005 | EP1534748A2 Fusion proteins and methods of producing same |
| 06/01/2005 | EP1534739A2 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 06/01/2005 | EP1534738A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/01/2005 | EP1534736A2 Nogo receptor antagonists |
| 06/01/2005 | EP1534731A1 Bmp-2 estrogen responsive element and methods of using the same |
| 06/01/2005 | EP1534631A1 Method for the production of highly organized crystals by means of sol-gel methods |
| 06/01/2005 | EP1534390A2 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 06/01/2005 | EP1534332A2 Antibodies and uses thereof |
| 06/01/2005 | EP1534328A2 Protective antigens for the control of ixodes species infestations |
| 06/01/2005 | EP1534322A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 06/01/2005 | EP1534318A2 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 06/01/2005 | EP1534306A2 Defensins: use as antiviral agents |
| 06/01/2005 | EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/01/2005 | EP1534068A2 Compositions and methods for neural differentiation of embryonic stem cells |
| 06/01/2005 | EP1534066A2 Alpha(1,3)-galactosyltransferase null cells, methods of selecting and alpha(1,3)-galactosyltransferase null swine produced therefrom |
| 06/01/2005 | EP1534064A2 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 06/01/2005 | EP1465992A4 Pluripotent stem cells derived without the use of embryos or fetal tissue |
| 06/01/2005 | EP1451291A4 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 06/01/2005 | EP1435779A4 Modulation of stem cells using zinc finger proteins |
| 06/01/2005 | EP1339747B1 Membrane fusion proteins derived from reovirus |
| 06/01/2005 | EP1311162B1 Bacillus thurigiensis crystal protein hybrids |
| 06/01/2005 | EP1100878B1 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |